Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy decision coaching for people with multiple sclerosis - Implementation of an interprofessional decision support programme into clinical practice.

Multiple sclerosis and related disorders·2026
Same author

Development and Validation of a Novel Stenosis Model for Percutaneous Transluminal Angioplasty Training of the Internal Carotid Artery.

Clinical neuroradiology·2025
Same author

Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].

Patient education and counseling·2024
Same author

Evaluation of an Image-based Classification Model to Identify Glioma Subtypes Using Arterial Spin Labeling Perfusion MRI On the Publicly Available UCSF Glioma Dataset.

Clinical neuroradiology·2024
Same author

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation.

Patient education and counseling·2024
Same author

Adherence coaching is not shared-decision making!

Multiple sclerosis and related disorders·2024
Same journal

Microglial brain-derived neurotrophic factor (BDNF) supports the behavioral and synaptogenic effects of ketamine.

Brain, behavior, and immunity·2026
Same journal

Hippocampal C5a-C5aR1 axis drives age-related memory decline via collapsing synaptic chloride homeostasis.

Brain, behavior, and immunity·2026
Same journal

Bifidobacterium bifidum TMC3115-RAW264.7 cell conditioned mediums promote the synaptic development of primary hippocampal neuron via activating IL-6/JAK2/STAT3 signaling pathway.

Brain, behavior, and immunity·2026
Same journal

T cells contribute to approaching positive but potentially risky stimuli through medial prefrontal cortex immune modulation.

Brain, behavior, and immunity·2026
Same journal

Insulin modulates mPFC gene expression and emotional behavior in a sex-specific manner following fetal growth restriction.

Brain, behavior, and immunity·2026
Same journal

Activation of the cGAS-STING pathway contributes to cancer-related fatigue in a murine model of head and neck cancer.

Brain, behavior, and immunity·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Correlates of cognitive dysfunction in multiple sclerosis.

C Heesen1, K H Schulz, J Fiehler

  • 1Institute of Neuroimmunology and Clinical MS Research, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany. heesen@uke.uni-hamburg.de

Brain, Behavior, and Immunity
|July 13, 2010
PubMed
Summary
This summary is machine-generated.

Fatigue and depression are key factors in multiple sclerosis (MS) cognitive impairment, impacting attention and memory. Understanding these links is crucial for managing MS symptoms and improving patient care.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: Jun 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • Cognitive impairment is a common, yet poorly understood, symptom in multiple sclerosis (MS).
  • Previous research has proposed various factors like psychosocial issues, inflammation, and neurodegeneration, but these haven't been studied concurrently.
  • The specific contributions of these systems to MS-related cognitive decline remain unclear.

Purpose of the Study:

  • To investigate the parallel contributions of psychosocial factors, inflammation, and neuroendocrine function to cognitive impairment in MS patients.
  • To identify the primary correlates of cognitive dysfunction in a well-characterized MS cohort.

Main Methods:

  • A cohort of 50 MS patients (25 cognitively impaired, 25 cognitively preserved) underwent comprehensive neuropsychological testing.
  • Evaluated hypothalamo-pituitary-adrenal (HPA) axis function using the dexamethasone-corticotropin-releasing hormone (Dex-CRH) suppression test.
  • Assessed peripheral blood markers (T-cell activation) and MRI for inflammation and atrophy.

Main Results:

  • Cognitively impaired MS patients exhibited higher disability, fatigue, and depression levels.
  • Fatigue correlated with attention measures; depression correlated with memory tests.
  • T-cell activation showed modest links to processing speed and working memory; MRI markers were not associated with cognitive function.
  • HPA axis hyperactivity was infrequent and not linked to neuropsychological performance.

Conclusions:

  • Fatigue and depression are the principal correlates of cognitive impairment in MS.
  • These factors demonstrate domain-specific associations, with fatigue affecting attention and depression impacting memory.
  • Inflammation and HPA axis dysfunction appear less critical in this cohort's cognitive decline compared to psychosocial factors.